“The World is Flat”, says Thomas Friedman. Telecommunication companies spent millions of dollars, given to “wire the world,” laying fiber-optic cable across the ocean floors, connecting India, Bangkok, and China to the advanced industrial countries.
World-wide Granted Patents, “The World is Spiky” notes Richard Florida in the Atlantic Monthly. In terms of both economic strength and cutting-edge innovation, just a few world centers influence today’s global economy.
World Population Centers- Globalization has increased access to the greater populous areas worldwide and has increased the returns to innovation by allowing products and services to reach consumers throughout the world.
As noted by Friedman, China and India represent great opportunities to innovation centers of the world, such as the U.S. by the net effect of adding hundreds of millions of people, not only outsourced workers, but in this new economy, increasingly wealthy consumers. Thus transfer of products and services, can now more forcibly be passed from the innovators to the global consumer.
"In a flat world you can innovate without having to emigrate."
Author and Columnist, New York Times
If you are an emerging growth company in the biomedical, medical device, biotech or pharmaceutical industry, the opportunities for expansion in a global market must be analyzed. The Asia-Pacific region, specifically China, with its increasing base of consumers having more discretionary income and increased wealth, creates an ideal environment to tap as new markets for technology adoption.
China’s rapidly growing economy creates an attraction and those companies that fail to act quickly can find themselves shut out of this market by competitors that had the foresight for early entry.
This process can be challenging and difficult. To be successful you must be able to navigate the political, regulatory and cultural issues, to establish long-term cooperative partnerships and strategic relationships. With our understanding of Chinese policies and with appropriate connections (guanxi), we can help American enterprises navigate these treacherous pathways through Chinese policies and regulation.
We can assist you in developing the right market and distribution channels for your product, as well as find the right Partners for a strategic collaboration or Joint Venture. We can assist in the regulatory pathway through the NMPA-National Medical Products Administration (Chinese regulatory Board) and submissions for approval.
If you are in need of further funding of your enterprise to allow expansion or growth, we have the resources to assist this process. We have access to capital and/or debt financing to accomplish your goals as you continue to grow your revenue either from new market entry or by acquisition. We can help identify projects in the Asia-Pacific regions or closer to home and can offer advice on specific approaches and negotiating strategies. We can provide advisors with an in-depth knowledge of business practices, legal issues, cultural and regulatory concerns, all necessary for a successful entry into these lucrative markets.
Finally, a highly effective means to control manufacturing costs is outsourcing of production to the increasingly technical Chinese manufacturing community. The concerns for protection of intellectual property can be addressed and the appropriate manufacturer identified. Important elements in an outsourcing relationship can be painful experiences, but the right strategic plan, intensive analysis, and assistance can prevent catastrophe and lay the groundwork for a truly rewarding outsource implementation policy.
Consultation, Assistance, Service
• Identify Distribution Opportunities, Partners, Joint Ventures
• Guidance for Product Registration (NMPA), Regulatory Issues
• Intellectual Property Assessment
• Develop Successful Business Strategy
• Investment Advisory